Patient sample | ALL5 | ALL6 | ALL10 | ALL12 | ALL16 | ALL17 | ALL18 | ALL19 | ALL20 | ALL 21 |
---|---|---|---|---|---|---|---|---|---|---|
Age (years.months) | 14.5 | 5.0 | 15.6 | 3.4 | 2.8 | 3.2 | 6.5 | 7.5 | 7.4 | 11.7 |
Sex | Female | Female | Female | Female | Male | Male | Male | Male | Male | Male |
Sample from relapse | No | Yes | No | No | No | No | No | No | No | No |
Immunophenotype | Common-B | Common-B | Common-B | Pre-B | Pre-B | Pre-B | Pre-B | Pre-B | Pre-B | Pre-B |
Cytogenetics | t(9;22) | Normal karyotype | t(12;21)t(5;17) | t(12;21)(p13;q22) | 47 ~ 48,XY,+X,i(21)(q10),+ i(21)(q10),[cp9]/46,XY[1] | 46 XY, - 21c | t(12,21) | 44, X,-Y,t(4;14) (q25;q32 | 46,XY,t(1;19)(q(23;p13)[2]/46,XY[23] | t(12;21)(p13;q22) |
Residual disease at day 15 | 42 × 10-2 | Not performed | 30 × 10-2 | 1.1 × 10-2 | 3.2 × 10-3 | 8.9 × 10-3 | 8 × 10-3 | No MRD | 5 x 10-3 | No MRD |
Residual disease at day 29 | 27 × 10-2 | No MRD | 7.3 × 10-3 | 3 × 10-4 | No MRD | 9 × 10-4 | 5 × 10-4 | No MRD | No MRD | No MRD |